Stocks

Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea

ByVandana Singh

Jul 19, 2022
Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea

[ad_1]

  • The DEKRA Notified Body has approved the use of Nyxoah SA’s NYXH next-generation Genio 2.1 system for patients in Europe. 

  • Genio 2.1 is a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy for Obstructive Sleep Apnea.

  • As with the recent approval of Genio 2.1 by the FDA for use in the DREAM U.S. IDE pivotal study, this CE mark pertains entirely to the external components of the Genio system. 

  • Related: FDA Signs Off Nyxoah’s Genio Trial In Complete Concentric Collapse Patients.

  • It will be available to all patients who have received Genio implants.

  • Genio 2.1 is designed to improve patient comfort and compliance with a new smartphone application and upgraded external activation chip. 

  • Genio 2.1 offers patients daily feedback on therapy usage and the autonomy to adjust stimulation amplitude within pre-defined boundaries. 

  • Physicians can fine-tune stimulation amplitude to determine the optimal comfort level for patients without compromising therapy efficacy. 

  • Additional embedded sensors will allow physicians to further tailor therapy stimulation parameters based on patient position and throughout the night. 

  • Price Action: NYXH shares closed 1.69% higher at $9.00 on Monday.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.

By Vandana Singh

Related Post

Stocks

Costco Stock Is Moving Higher After Hours: What’s Going On?

Jan 19, 2023 Adam Eckert
Stocks

Alphabet (Google) Stock Surges, Showing More Strength Than Broader Market: What’s Next?

Jan 19, 2023 Melanie Schaffer
Stocks

Stifel Maintains Hold Rating for Matson: Here’s What You Need To Know

Jan 19, 2023 Benzinga Insights

You missed

Stocks

Costco Stock Is Moving Higher After Hours: What’s Going On?

Jan 19, 2023 Adam Eckert
Crypto

FTX Cannot Be Saved, Sam Betrayed Me

Jan 19, 2023 Dalmas Ngetich
Commodities

Netflix Q4 Results Screening: Shares Fast Forward On Revenue Beat, Subscriber Jump, Strong Forecast

Jan 19, 2023 Adam Eckert
Forex

Yen edges higher ahead of Tokyo CPI

Jan 19, 2023 Kenny Fisher